News Daily News Diabetes Drug Canagliflozin Gets MACE Reduction Indication Todd Neale November 01, 2018
News Daily News FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients Todd Neale October 12, 2018
News Daily News Church-Based Lifestyle Intervention Shows Promise for Lowering BP in Hypertensive African-Americans Todd Neale October 09, 2018
News Daily News Add-on Payment Now in Effect for Sentinel Protection Device During TAVR Todd Neale October 01, 2018
News Conference News TCT 2018 Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released Todd Neale September 24, 2018
News Conference News TCT 2018 TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers Todd Neale September 22, 2018
News Daily News FDA Approves New Covered Stent Option for Coronary Perforations Todd Neale September 14, 2018
News Daily News Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’ Todd Neale September 13, 2018
News Daily News TAVR Learning Curve, Volume-Outcome Relationship Highlighted in International Registry Todd Neale September 11, 2018
News Daily News Newly Defined Stage 1 Hypertension Tied to CVD Risk in Younger Chinese Adults Todd Neale September 07, 2018
News Conference News ESC 2018 Myocardial Injury or MI? New Universal Definition Aims for Clarity Todd Neale September 05, 2018
News Conference News ESC 2018 Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD Todd Neale August 31, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Daily News Experts Give Strong Support for PFO Closure in New ‘Rapid Recommendations’ Todd Neale July 26, 2018
News Daily News Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality Todd Neale July 18, 2018